Evidence map›Paper›PMID 31195737›Full record

ArticleMarine drugs2019

Jihui Wang, Shiwen Liu, Han Wang, Shan Xiao, Cheng Li, Ying Li, Bingnan Liu

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Polysaccharide fromFoods (Basel, Switzerland) · 2021
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Astaxanthin InhibitsJournal of cancer prevention · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jihui WangEngineering Research Center of Health Food Design & Nutrition Regulation, School of Chemical Engineering and Energy Technology, Dongguan University of Technology, Dongguan 523808, China. wangjh_dlpu@163.com.
Shiwen LiuEngineering Research Center of Health Food Design & Nutrition Regulation, School of Chemical Engineering and Energy Technology, Dongguan University of Technology, Dongguan 523808, China. ykslsw@163.com.
Han WangSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China. hwang@dlpu.edu.cn.
Shan XiaoEngineering Research Center of Health Food Design & Nutrition Regulation, School of Chemical Engineering and Energy Technology, Dongguan University of Technology, Dongguan 523808, China. xiaoshan@dlpu.edu.cn.
Cheng LiSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China. licheng19850724@126.com.
Ying LiSchool of Food Science and Engineering, Dalian Ocean University, Dalian 116023, China. liying@dlou.edu.cn.
Bingnan LiuSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China. lbnno158@foxmail.com.ORCID 0000-0001-6850-8466
Dalian Polytechnic University · CNDongguan University of Technology · CNDalian Ocean University · CN

Funding

Dalian Science and Technology Innovation Fund 2018J11CY028Institute of Science and Technology Innovation, Dongguan University of Technology No.KCYCXPT2017007; GB200902-51National Natural Science Foundation of China 31701587Natural Science Foundation of Liaoning Province 20170520198
6 · The paper itself

Abstract

Astaxanthin is an important antioxidant with many biological activities such as anti-tumor, anti-obesity, cardioprotective, and immuno-modulatory activities. Most of these biological activities are derived from (3S,3'S)-astaxanthin, while the activities of (3R,3'R)-astaxanthin are rarely reported. The purpose of this study was to investigate the effect of (3R,3'R)-astaxanthin on lipid metabolism and gut microbiota in mice fed with a high-fat diet. In this work, 40 male C57BL/6 mice were divided into 8 groups fed a high-fat diet supplemented or not with (3R,3'R)-astaxanthin or

Indexed as

Diet, High-FatAnimalsBasidiomycotaGastrointestinal MicrobiomeLipid MetabolismMaleMiceMice, Inbred C57BLMice, ObeseXanthophyllsastaxanthineXanthophyllsastaxanthingut microbiotalipid metabolismobesityXanthophyllomyces dendrorhous

Identifiers

PMID31195737
PMCPMC6627754
OpenAlexW2949019404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.